CCMH
HAE icon

Cornerstone Capital Management Holdings’s Haemonetics HAE Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.7M Buy
+29,300
New +$1.54M 0.01% 806
2017
Q2 		– Sell
-22,825
Closed -$926K – 1292
2017
Q1 		$926K Sell
22,825
-149,060
-87% -$5.82M 0.01% 944
2016
Q4 		$6.91M Buy
171,885
+84,700
+97% +$3.19M 0.05% 375
2016
Q3 		$3.16M Buy
+87,185
New +$2.99M 0.02% 608

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Capital Management Holdings's HAE Position: Q4 2017 in Review

Cornerstone Capital Management Holdings opened a new position in Haemonetics (HAE) in Q4 2017: 29,300 shares worth $1.7M. The stake represents 0.01% of the portfolio and ranks #806 among its holdings. This is a return to the name: Cornerstone Capital Management Holdings previously reported a position in HAE as recently as Q1 2017.

Cornerstone Capital Management Holdings first reported a position in HAE in Q3 2016 and has held it in 4 quarters since. The position peaked at $6.91M in Q4 2016. 246 funds tracked by Wall St. Rank hold HAE as of Q4 2017.

  • Cornerstone Capital Management Holdings held 29,300 shares of Haemonetics worth $1.7M as of Q4 2017.
  • Haemonetics was a new Cornerstone Capital Management Holdings position in Q4 2017.
  • Haemonetics made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #806 holding.
  • Cornerstone Capital Management Holdings first reported a position in Haemonetics in Q3 2016 and has held it in 4 quarters since.
  • Cornerstone Capital Management Holdings's Haemonetics position peaked at $6.91M in Q4 2016.
  • 246 funds tracked by Wall St. Rank held Haemonetics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.